Please Wait
| Date | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $203,971.00 | $531,393.00 | -- | -- | $31,573.00 | -- | -- | -- | -- |
| Accounts Receivable Net Current | $31,948.00 | -- | -- | -- | $344,924.00 | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Prepaid Expenses and Other Current Assets | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Current Assets | $266,453.00 | $621,382.00 | -- | -- | $409,776.00 | -- | -- | -- | -- |
| Property Plant and Equipement | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Intangible Assets Net | $71,864.00 | $8,750.00 | -- | -- | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Other Assets | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Assets | $548,950.00 | $809,640.00 | -- | -- | $531,131.00 | -- | -- | -- | -- |
| Accounts Payable | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Accrued Liabilities | -- | -- | -- | -- | $105,000.00 | -- | -- | -- | -- |
| Total Current Liabilities | $251,857.00 | $305,742.00 | -- | -- | $598,887.00 | -- | -- | -- | -- |
| Long Term Debt | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Additional Paid-in Capital | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Accumulated Other Comprehensive Loss | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Accumulated Deficit | $-5,021,696.00 | $-4,609,892.00 | -- | -- | $-3,655,378.00 | -- | -- | -- | -- |
| Total Stockholders' Equity | $297,093.00 | $503,898.00 | $74,277.00 | $-15,095.00 | $-67,756.00 | $-209,243.00 | $-217,418.00 | $-376,235.00 | $-307,000.00 |
| Controlling Interest in Subsidiaries | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Liabilities and Equity | $548,950.00 | $809,640.00 | -- | -- | $531,131.00 | -- | -- | -- | -- |
| Date | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Cost of Revenues | $36,701.00 | $36,701.00 | -- | -- | -- | $1,426.00 | -- | -- | -- |
| Gross Profit | $164,358.00 | $132,410.00 | -- | -- | -- | $113,574.00 | -- | -- | -- |
| Research and Development | $11,416.00 | $8,803.00 | -- | -- | -- | -- | -- | -- | -- |
| Selling, General, and Administrative | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Operating Expenses | $1,529,067.00 | $1,082,783.00 | -- | -- | -- | $310,639.00 | -- | -- | -- |
| Loss from Operations | $-1,364,709.00 | $-950,373.00 | -- | -- | -- | $-197,065.00 | -- | -- | -- |
| Loss Before Income Taxes | $-1,366,318.00 | $-954,514.00 | -- | -- | -- | $8,175.00 | -- | -- | -- |
| Earnings Per Share Basic | $-0.01 | $-0.01 | -- | -- | -- | -- | -- | -- | -- |
| Weighted Average Shares Basic | 104,116,589 | 103,083,257 | -- | -- | -- | 91,735,159 | -- | -- | -- |
| Earnings Per Share Diluted | $-0.01 | -- | -- | -- | -- | -- | -- | -- | -- |
| Weighted Average Shares Diluted | 104,116,589 | 103,083,257 | -- | -- | -- | 98,735,159 | -- | -- | -- |
| Common Stock Shares Authorized | 1,000,000,000 | 1,000,000,000 | -- | -- | 1,000,000,000 | -- | -- | -- | -- |
| Common Stock Shares Outstanding | 109,790,991 | 108,715,991 | -- | -- | 100,735,159 | -- | -- | -- | -- |
| Common Stock Value | $471,569.00 | $471,472.00 | -- | -- | $470,673.00 | -- | -- | -- | -- |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | -- | -- | $0.00 | -- | -- | -- | -- |
| Payments Of Dividends Common Stock | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Preferred Stock Shares Authorized | 1,000,000 | 1,000,000 | -- | -- | 1,000,000 | -- | -- | -- | -- |
| Preferred Stock Shares Outstanding | 3,829 | 3,829 | -- | -- | 3,829 | -- | -- | -- | -- |
| Preferred Stock Value | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | -- | -- | $0.00 | -- | -- | -- | -- |
| Share Price | -- | -- | -- | -- | -- | -- | -- | -- | -- |